Literature DB >> 14575364

A vision for cancer incidence surveillance in the United States.

Holly L Howe1, Brenda K Edwards, John L Young, Tiefu Shen, Dee W West, Mary Hutton, Catherine N Correa.   

Abstract

A comprehensive framework for cancer surveillance should span the entire lifespan and be capable of providing information on risk, burden, disparity, cost, cancer care, survival, and death. Cancer incidence, the point in the continuum when an individual is diagnosed with cancer, has a strong, well-developed system to produce information about newly diagnosed cancer cases. However, in the future, this system must be enhanced and integrated with other cancer surveillance networks and other systems to provide timely information on the burden of newly diagnosed patients with respect to various cross-cutting population characteristics (e.g., social, economic, race/ethnic, urbanicity, or access to care) to define, monitor, and reduce incidence and various disparities noted among population groups. Collaboration in data collection, standard setting, surveillance activities, research, education and training, data use, and advocacy among all registries and national programs will be important to the continued success of the cancer incidence surveillance system. The cancer registry is an integral part of the infrastructure to reduce the burden of cancer, including the numbers of newly diagnosed cases.

Entities:  

Mesh:

Year:  2003        PMID: 14575364     DOI: 10.1023/a:1025667524781

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  8 in total

1.  Availability and utility of body mass index for population-based cancer surveillance.

Authors:  Theresa H M Keegan; Gem M Le; Laura A McClure; Sally L Glaser
Journal:  Cancer Causes Control       Date:  2007-10-18       Impact factor: 2.506

2.  The California Neighborhoods Data System: a new resource for examining the impact of neighborhood characteristics on cancer incidence and outcomes in populations.

Authors:  Scarlett Lin Gomez; Sally L Glaser; Laura A McClure; Sarah J Shema; Melissa Kealey; Theresa H M Keegan; William A Satariano
Journal:  Cancer Causes Control       Date:  2011-02-12       Impact factor: 2.506

3.  Research recruitment through US central cancer registries: balancing privacy and scientific issues.

Authors:  Laura M Beskow; Robert S Sandler; Morris Weinberger
Journal:  Am J Public Health       Date:  2006-03-29       Impact factor: 9.308

4.  Utility and Generalizability of Multistate, Population-Based Cancer Registry Data for Rural Cancer Surveillance Research in the United States.

Authors:  Whitney E Zahnd; Wiley D Jenkins; Aimee S James; Sonya R Izadi; David E Steward; Amanda J Fogleman; Graham A Colditz; Laurent Brard
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-03-21       Impact factor: 4.254

5.  A new method to evaluate the completeness of case ascertainment by a cancer registry.

Authors:  Barnali Das; Limin X Clegg; Eric J Feuer; Linda W Pickle
Journal:  Cancer Causes Control       Date:  2008-02-13       Impact factor: 2.506

6.  Cancer incidence trends among Asian American populations in the United States, 1990-2008.

Authors:  Scarlett Lin Gomez; Anne-Michelle Noone; Daphne Y Lichtensztajn; Steve Scoppa; James T Gibson; Lihua Liu; Cyllene Morris; Sandy Kwong; Kari Fish; Lynne R Wilkens; Marc T Goodman; Dennis Deapen; Barry A Miller
Journal:  J Natl Cancer Inst       Date:  2013-07-22       Impact factor: 13.506

7.  Incidence and risk factors of HPV-related and HPV-unrelated Head and Neck Squamous Cell Carcinoma in HIV-infected individuals.

Authors:  Daniel C Beachler; Alison G Abraham; Michael J Silverberg; Yuezhou Jing; Carole Fakhry; M John Gill; Robert Dubrow; Mari M Kitahata; Marina B Klein; Ann N Burchell; P Todd Korthuis; Richard D Moore; Gypsyamber D'Souza
Journal:  Oral Oncol       Date:  2014-10-06       Impact factor: 5.337

Review 8.  Cancer in indigenous people in Latin America and the Caribbean: a review.

Authors:  Suzanne P Moore; David Forman; Marion Piñeros; Sdenka M Fernández; Marceli de Oliveira Santos; Freddie Bray
Journal:  Cancer Med       Date:  2013-12-03       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.